We are live on
!
Find out more
CCM
Cadence Capital Management Portfolio holdings
AUM
$415M
1-Year Est. Return
11.01%
This Fund
S&P 500
This Quarter
Est. Return
+3.33%
1 Year Est. Return
-11.01%
3 Year Est. Return
+0.72%
5 Year Est. Return
+39.08%
10 Year Est. Return
–
AUM
$2.37B
AUM Growth
-$263M
(-10%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-12.69%
Top 10 Holdings %
Top 10 Hldgs %
8.72%
Holding
727
New
125
Increased
110
Reduced
349
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$12.6M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$12.3M |
| 3 |
Home Depot
HD
|
+$12M |
| 4 |
Colgate-Palmolive
CL
|
+$11.9M |
| 5 |
General Motors
GM
|
+$10.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$14.9M |
| 2 |
HSNI
HSN, Inc.
HSNI
|
+$13.1M |
| 3 |
US Bancorp
USB
|
+$13M |
| 4 |
VeriSign
VRSN
|
+$12.4M |
| 5 |
PNC Financial Services
PNC
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 15.97% |
| 2 | Technology | 15.08% |
| 3 | Consumer Discretionary | 13.32% |
| 4 | Healthcare | 12.89% |
| 5 | Financials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXON
401
Axon Enterprise
AXON
$49.1B
| $1.25M | 0.05% |
68,602
+33,438
| +95% | +$598K |
|
402
Ares Capital
ARCC
$13.9B
| $1.25M | 0.05% |
70,989
-6,604
| -9% | -$118K |
|
|
SCMP
403
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $1.25M | 0.05% |
174,145
+29,840
| +21% | +$255K |
|
|
CVO
404
DELISTED
Cenevo, Inc.
CVO
| $1.24M | 0.05% |
51,008
+8,813
| +21% | +$236K |
|
405
AXIS Capital
AXS
$7.61B
| $1.23M | 0.05% |
26,783
-6,877
| -20% | -$308K |
|
406
Harvard Bioscience
HBIO
$28.7M
| $1.23M | 0.05% |
25,892
+716
| +3% | +$32.6K |
|
|
ARC
407
DELISTED
ARC Document Solutions, Inc.
ARC
| $1.22M | 0.05% |
+164,227
| New | +$1.23M |
|
|
EVRI
408
DELISTED
Everi Holdings
EVRI
| $1.22M | 0.05% |
177,963
+49,093
| +38% | +$418K |
|
409
AngioDynamics
ANGO
$622M
| $1.22M | 0.05% |
77,249
+22,579
| +41% | +$368K |
|
410
Simulations Plus
SLP
$371M
| $1.21M | 0.05% |
181,768
+6,249
| +4% | +$35.7K |
|
411
Avery Dennison
AVY
$13.4B
| $1.21M | 0.05% |
23,847
-4,894
| -17% | -$244K |
|
|
BMCH
412
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.21M | 0.05% |
59,457
+157
| +0.3% | +$3.01K |
|
|
FARM
413
DELISTED
Farmer Brothers
FARM
| $1.2M | 0.05% |
+60,745
| New | +$1.3M |
|
|
LTS
414
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $1.19M | 0.05% |
+394,810
| New | +$1.11M |
|
415
Tandem Diabetes Care
TNDM
$1.34B
| $1.19M | 0.05% |
+5,371
| New | +$1.37M |
|
|
ATRS
416
DELISTED
Antares Pharma, Inc.
ATRS
| $1.18M | 0.05% |
337,592
+58,082
| +21% | +$258K |
|
|
WIN
417
DELISTED
Windstream Holdings Inc
WIN
| $1.17M | 0.05% |
18,110
-3,056
| -14% | -$189K |
|
418
Herbalife
HLF
$1.31B
| $1.17M | 0.05% |
40,772
-119,928
| -75% | -$3.96M |
|
419
GameStop
GME
$8.53B
| $1.17M | 0.05% |
+113,596
| New | +$1.09M |
|
420
Copa Holdings
CPA
$6.15B
| $1.16M | 0.05% |
+7,955
| New | +$1.11M |
|
|
AVTA
421
DELISTED
Avantax, Inc. Common Stock
AVTA
| $1.15M | 0.05% |
58,292
+9,988
| +21% | +$231K |
|
|
PPL
422
PPL Corp
PPL
$26.3B
| $1.14M | 0.05% |
36,825
-6,814
| -16% | -$198K |
|
423
Equity Residential
EQR
$25.4B
| $1.13M | 0.05% |
19,549
-3,586
| -16% | -$202K |
|
424
Comfort Systems
FIX
$61.1B
| $1.13M | 0.05% |
74,155
+12,695
| +21% | +$217K |
|
425
Prologis
PLD
$131B
| $1.13M | 0.05% |
27,674
-3,309
| -11% | -$130K |
|
Similar funds
MGAI
FA
LWS
VCP
AIM
F
CPF
IA
Cadence Capital Management's Q1 2014 Portfolio in Review
As of Q1 2014, Cadence Capital Management held 727 positions worth $2.37B, down 10% from $2.64B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Cadence Capital Management withdrew a net $301M in Q1 2014, closing 143 positions and reducing 349 holdings. Its most notable exit was HSN, Inc., an estimated $13.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cadence Capital Management opened a new position in Boeing worth $12.2M.
- Cadence Capital Management's largest Q1 2014 buy was Boeing: 96,989 shares worth $12.2M.
- Cadence Capital Management added most to SCIQUEST, INC. COMMON STOCK in Q1 2014, an estimated $6.56M increase.
- Cadence Capital Management's biggest Q1 2014 reduction was Coca-Cola, cutting an estimated $14.9M.
- Cadence Capital Management fully exited HSN, Inc. in Q1 2014, selling an estimated $13.1M.
- Cadence Capital Management's ten largest holdings make up 8.7% of its $2.37B portfolio in Q1 2014.
- Cadence Capital Management opened 125 new positions and closed 143 in Q1 2014.
- Cadence Capital Management's portfolio value fell 10% quarter-over-quarter to $2.37B.
Based on Cadence Capital Management's 13F filing for Q1 2014, filed 28 Apr 2014.